Grants
-
New development of oHSV-Gluc biotechnology
-
Grant for the attendance at DeSci meeting, Amsterdam, 20 April 2022 Expired
-
Grant for the attendance at DAO Global Governance Gathering, Amsterdam, 18-19 April 2022 Expired
-
New development of oHSV for cancer treatment
-
Preclinical study of amphiphilic amines (RC16) for cancer treatment
-
Discovery of novel pathogenic bacterial essential proteins
-
Discovery of new targets for cancer immunotherapy
-
Animal study of Pseudomonas aeruginosa for cholesteatoma treatment
-
Develop 2nd generation microbial fuel cell: Pseudomonas aeruginosa for the killing of pathogens in electrogenic bioreactor
-
Further development Genetics Rights Management (GeRM) for controlling the release of microorganism